Research & Development: Page 58

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Global: A Shrinking World

    Taren Grom Global reach, emerging markets, and cross-divisional ­ expertise are playing an increasing role in all aspects of the life sciences, from R&D and clinical trials to sales and marketing. According to the IMS Institute for Healthcare Informatics, pharm­erging markets will approach U....

    By Taren Grom • Nov. 11, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    R&D: The Drug Device Conundrum

    Combining molecules with devices continues to be an evolving trend, but a lot of uncertainty exists around these combination products. There has been a movement toward convergence of technologies. More and more, drugs are being delivered or used in combination with a device with the intent to red...

    By Denise Myshko • Nov. 11, 2011
  • cancer healthcare Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Oncology

    As investments in cancer R&D stay high, waves of innovative new treatments are on the horizon.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    R&D: Global Regulatory Oversight

    Growing regulatory requirements, continued standardization of submission and data requirements, and a continued focus on safety are just a few of the issues facing pharmaceutical companies. “With the FDA’s recent ­acceptance into PIC/S, an ­international agreement between countries’ regulatory ag...

    By Denise Myshko • Nov. 11, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    R&D: Strategic Outsourcing

    CROs and pharmaceutical companies continue to finetune their strategic partnerships to gain a competitive edge. “”Companies are looking at ­outsourcing models that allow for sharper research focus, enhanced quality, improved efficiency, and offer a lower and more flexible cost base. " Alan Morgan...

    By Denise Myshko • Nov. 11, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The C-Suite: Corporate Strategies

    New Ways Forward Experts agree the time has come to re-evaluate the overall working culture of the life-sciences industry, and they say innovation, new payer models, new stakeholders, and new outcomes are key considerations for future success. “Pharma will need to generate data that are timely, r...

    By PharmaVoice Team • Nov. 11, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    C-Suite: Executive Insights

    CEOs, presidents, and executive management team members from across the industry — pharmaceutical, biotechnology, and service companies — discuss the most crucial factors driving change in the industry, as well as their strategies for meeting the challenges of business in the coming years. Jed Be...

    By PharmaVoice Team • Nov. 11, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Year of the Extreme Makeover

    Every sector in the industry is in a state of flux. In this special issue of PharmaVOICE, more than 160 thought leaders throughout the life-sciences industry discuss the changing market dynamics. According to PricewaterhouseCooper’s 14th Annual Global CEO Survey, which looks at the concerns expre...

    By Denise Myshko and Robin Robinsons • Nov. 11, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Percival BARRETTO-KO Astellas Realigns Executive Team Astellas US, the U.S. affiliate of Tokyo-based Astellas Pharma, has named Percival Barretto-Ko senior VP, corporate strategy and government affairs. Mr. Barretto-Ko was previously executive director, corporate strategy and ...

    By PharmaVoice Team • Nov. 11, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Sales, marketing, And R&D?Trends affecting the healthcare industry Healthcare Reform Viewed as Mixed Blessing Trend: Consumers believe the success of healthcare reform is dependent on achieving cost ­reduction and quality improvement — two things that traditionally stand in opposition to each...

    By Carolyn Gretton • Nov. 11, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    Industry Events and Conferences, including SPECIAL DISCOUNTS Coming ATTRACTIONS Attendees interested in maximizing their clinical trial performance by bridging the gap between identifying and implementing metrics, learning about best practices on processing data and on-site performance to improve...

    By PharmaVoice Team • Nov. 11, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Connecting with Professional and Patient Targets: Going Back to the Future with Live Telephone Interviewing

    More than a decade ago, the Internet took the market research world by storm. Online studies offer a fast, simple, cost-effective way to reach target audiences. A wide range of factors, however, often makes healthcare projects difficult to complete using online alone: Gatekeepers — such as office...

    By Chris De Angelis • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Hello South Africa

    A Diverse and Sophisticated Market With a diverse population, a thriving research environment, strong infrastructure along with geographic reach into the rest of Africa, South Africa has many advantages for the global pharma industry. With its population of more than 50 million people from divers...

    By Kim Ribbink • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    New Science Means New Ways to Target Disease

    Epigenetics — the study of changes in gene expression — is ­rapidly ­emerging as a field that presents tremendous opportunity for drug discovery. We are on the edge of a new biology. It turns out that our genes are just part of the story about what makes us who we are. Much has been learned over ...

    By Denise Myshko • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    30 Years of AIDS Research

    Antiretroviral agents have revolutionized treatment for HIV/AIDS. But there is still a ­tremendous need for prevention and less-costly therapies. Much progress has been made over the last 30 years in the HIV/AIDS arena. HIV infection is no longer considered a death sentence, thanks to antitretrov...

    By Denise Myshko • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    A Changing Market Environment Requires New PLM Strategies

    In a market environment that is increasingly value-based, the industry must begin to review its product life-cycle management (PLM) strategy and prepare for more effective ways to cope with the evolving challenges when it comes to pipeline maintenance. For example, companies need to start impleme...

    By Robin Robinson • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Taking Innovation to a New Level Ulrich Betz, Ph.D., Director at Merck Serono Portfolio Development and Head of the Department Center of Innovation, talks about fostering innovation and entrepreneurial thinking within the company. PV: What is the Merck Serono internal Innospire innovation program...

    By Ulrich Betz • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Pharma Trax

    Sales, marketing, And R&D?Trends affecting the healthcare industry Vision and Planning are Key to Efficient Real-World Data Use Trend: Market forces are driving the need for real-world data in the life-sciences industry. Recommendations for ­­Real-World Data Research » Develop a shared vision...

    By PharmaVoice Team • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Tools of the Trade

    New electronic and web-based applications, sites, and technologies POR Provides Real-Time Engagement Between Doctors and Brands Trend: Driven by physician access issues and shrinking sales forces, pharma brand marketers are looking for ways to use nonpersonal and digital promotion more effectivel...

    By PharmaVoice Team • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    New healthcare-related products, services, and companies Lumina Seeks to Support Medical Affairs Teams Trend: Pharma and biotech medical affairs organizations are playing an increasingly critical role in addressing the information needs of healthcare professionals and patients. KnowledgePoint360 ...

    By PharmaVoice Team • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Outlet

    Opinions, insights, and commentary from around the industry Getting to Variable Costs: Regulated Cloud-Sourcing Emerges Chuck Saldarini, CEO of Sentrx Safety ­Solutions, is redefining the standard for safety services by putting best practices into action, developing innovative solutions founded o...

    By Chuck Saldarini • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Impact of an Integrated Execution Environment on Data Management in Adaptive Clinical Trials

    Contributed By Corey B. Dunham, VP Data Management and Statistics, North America Anyone who has baked a cake can tell you that the quality of the ingredients is equally as important as following the recipe. Data quality in clinical trials is much the same way. You can follow the protocol and stan...

    By Corey B. Dunham • Aug. 29, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Decoding Data Dynamics

    By Carolyn Gretton The shift in life-sciences development toward more personalized therapeutics is driving a need for proactive clinical data management (CDM) strategies that take into account the volume and complexity of information emerging from today’s clinical trials. Data management is being...

    By Carolyn Gretton • Aug. 29, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Hola Mexico: Pharma Drawn to U.S. Neighbor

    By Kim Ribbin Growing health coverage, high medical standards, a ­motivated patient population, and huge geographic ­advantages make Mexico an appealing market for the ­pharmaceutical industry. With a population of around 110 million people and a growing focus on healthcare, Mexico has fast becom...

    By Kim Ribbink • Aug. 29, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Beyond Stem Cells

    By Denise Myshko It may seem like science fiction: a trachea grown from stem cells and implanted into a human being. But it’s not; this is an actual account of the power of stem cells and regenerative medicine. The 36-year-old patient, who had been suffering from late-stage tracheal cancer, recei...

    By Denise Myshko • Aug. 29, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Mentoring: More Crucial Than Ever

    By Robin Robinson With the industry in constant flux, industry leaders say mentoring is key for career advancement. Declining budgets, the emergence of small innovative startups with fewer resources, busy schedules, and an ever-changing work environment are a few of the factors that make mentorin...

    By Robin Robinson • Aug. 29, 2011